I enjoyed your editorial “Wish Lists and Wishful Thinking” (January 2003, p. 6). As a staffing consultant for On Assignment, Lab Support, I realize and understand the potential New York possesses for the scientific industry. I have met with startup companies at the local incubators and have also helped individuals find positions as many companies abandon their foundations for “greener pastures.” I like to look at it as the “Long Island Exodus.” I have served the genomics industry for three-plus years, with Celera Genomics in Rockville — the Biotechnological Corridor, as they call it.
After accomplishing and co-authoring the human and mouse genomes, I moved to New York City to identify the victims of September 11th with Project Soaring Eagle via mtDNA analysis. I decided to remain in New York and serve as a staffing consultant to a broad range of scientific institutions in the area. New York City and Long Island do have the potential to become the next biotechnological corridor and I appreciate you addressing that potential.
Reginald Thomas, Jr., Staffing Consultant, Lab Support
Watson by Degrees
I enjoyed the blurb on the second coming of James D. Watson (“Watson a Name? The Other James D. Goes to Burrill,” February 2003, p. 16). But, in drawing parallels between the two, how could you overlook the obvious — that both of them graduated from Indiana University (James the Original a PhD and James the Impostor an MBA)? Should I stop correcting people when they say GT only writes superficial news, and doesn’t scratch much below the surface? No, I think you do just fine. Thanks.
Paul Eder, Director, Message Pharmaceuticals
Send Us Your Message
Unless requested otherwise, any correspondence to Genome Technology may be published. Letters may be edited for length and clarity. Send mail to [email protected] or mail to:
Editor, Genome Technology,
PO Box 998, Peck Slip Station,
New York, NY 10272-0998